OSE Pharma SA (OSE) — Capital Reinvestment Ratio
OSE Pharma SA (OSE) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow (€66.63 Million) in capital expenditures (€18.00K). See OSE Pharma SA net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
OSE Pharma SA Capital Reinvestment Ratio (2016–2024)
This chart tracks OSE Pharma SA's Capital Reinvestment Ratio across 4 annual periods. Check OSE cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for OSE Pharma SA (2016–2024)
Year-by-year Capital Reinvestment Ratio for OSE Pharma SA from 2016 to 2024. For live market cap and broader valuation context, see OSE Pharma SA market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | €48.44 Million | €77.00K | ▼ -95.8% |
| 2019 | 0.04x | €8.97 Million | €336.00K | ▼ -93.2% |
| 2018 | 0.55x | €1.08 Million | €593.00K | ▲ +1155.4% |
| 2016 | 0.04x | €684.00K | €30.00K | — |